VANCOUVER, Dec. 8, 2016 /CNW/ - Reliq Health Technologies
Inc. (TSXV:RHT or OTCQB:RQHTF) ("Reliq" or the "Company"), a technology company focused on developing innovative
mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has opened an
office in the UK to support Reliq's expansion into the European market.
"We are very pleased to be opening an office in London, England in response to strong interest
from the UK market," said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. "Reliq
recently launched a pilot with the NHS England at Imperial College Hospital in London to validate
the use of our remote patient monitoring and care collaboration solution for patients with chronic conditions. Opening an
office in the UK allows us to better support this pilot and acquire new customers in the UK and the rest of Europe. Reliq's
virtual care platform was designed to reduce readmissions and improve health outcomes for patients with chronic conditions like
Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD) and Diabetes. Our technology allows patients to
receive high quality care from the comfort of their own homes, reducing the cost of care delivery and increasing patient and family
satisfaction."
Currently there are over 15 million people in England living with at least one long-term health
condition. In addition to the impact on people's lives, long-term condition management accounts for half of all General
Practitioner appointments and 70% of hospital bed days in the UK. Reliq Health's proprietary hardware and software supports
patients and their caregivers in the home, providing remote vitals monitoring with alerts to clinicians as needed, audible
reminders to improve patient compliance with prescribed medication regimens and lifestyle changes, tailored patient education and
secure communication with the entire care team.
Reliq's UK office is located at Impact Hub Westminster, 1st Floor New Zealand House, 80 Haymarket, London SW1Y 4TE. The entire funding for the UK office was provided by the UK Department of International
Trade's Global Entrepreneur Programme, which supports entrepreneurs and early stage technology businesses that wish to locate in
the UK.
ON BEHALF OF THE BOARD
"Dr. Lisa Crossley"
CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable
securities laws. All statements that are not historical facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are
"forward-looking statements".
We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual
and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including
technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future
results, estimates of amounts not yet determinable and assumptions of management.
Reliq Health Technologies Inc. (the "Company") does not intend, and does not assume any obligation, to update these
forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to,
among other things, technology development and marketing activities, the Company's historical experience with technology
development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking
statements.
SOURCE Reliq Health Technologies Inc.